Tearsheet

TNF Pharmaceuticals (TNFA)

Market Price (9/30/2025): $4.04 | Market Cap: $0.6 Mil
Sector: Health Care | Industry: Biotechnology

TNF Pharmaceuticals (TNFA)

Market Price (9/30/2025): $4.04
Market Cap: $0.6 Mil
Sector: Health Care
Industry: Biotechnology

Investment Highlights

0	Cash is significant % of market cap Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -517%	Weak multi-year price returns 2Y Excs Rtn is -153%, 3Y Excs Rtn is -177%	Very low revenue Rev LTMTotal Revenue or Sales, Last Twelve Months is 0
1			Not profitable at operating income level Op Inc LTMOperating Income, Last Twelve Months is -8.4 Mil
2			Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -941%
3			High stock price volatility Vol 12M is 7771%
4			Significant short interest Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 198%

0	Cash is significant % of market cap Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -517%
1	Weak multi-year price returns 2Y Excs Rtn is -153%, 3Y Excs Rtn is -177%
2	Very low revenue Rev LTMTotal Revenue or Sales, Last Twelve Months is 0
3	Not profitable at operating income level Op Inc LTMOperating Income, Last Twelve Months is -8.4 Mil
4	Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -941%
5	High stock price volatility Vol 12M is 7771%
6	Significant short interest Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 198%

Market Valuation

	9/30/25	2024	2023	2022	2021
Share Price CYE	$4.04	$115.00	$776.10	$3,450.00	$18,180.00
Market Cap CYE ($ Mil)	0.6	330.6	1,397.6	4,576.7	22,951.8
Total Debt ($ Mil)	0.0	0.0	0.0	0.1	0.1
Total Cash ($ Mil)	3.8	8.5	4.9	4.8	11.6
Enterprise Value ($ Mil)	-3.2	330.6	1,397.6	4,576.8	22,951.9
Valuation Ratios
P/S TTM	0.0	0.0	0.0	0.0	0.0
P/EBIT TTM	-0.1	0.0	-0.0	-0.0	-0.1
P/E TTM	-0.1	0.0	-0.0	-0.0	-0.1
Sector Ratios
P/S TTM (Sector)	3.7	3.6	4.0	4.5	7.3
P/EBIT TTM (Sector)	-1.6	-1.3	-1.4	-1.3	-2.8
P/E TTM (Sector)	-1.9	-1.5	-1.5	-1.3	-2.8

	9/30/25	2024	2023
Share Price CYE	$4.04	$115.00	$776.10
Market Cap CYE ($ Mil)	0.6	330.6	1,397.6
Total Debt ($ Mil)	0.0	0.0	0.0
Total Cash ($ Mil)	3.8	8.5	4.9
Enterprise Value ($ Mil)	-3.2	330.6	1,397.6
Valuation Ratios
P/S TTM	0.0	0.0	0.0
P/EBIT TTM	-0.1	0.0	-0.0
P/E TTM	-0.1	0.0	-0.0
Sector Ratios
P/S TTM (Sector)	3.7	3.6	4.0
P/EBIT TTM (Sector)	-1.6	-1.3	-1.4
P/E TTM (Sector)	-1.9	-1.5	-1.5

Stock Price
Market Cap

Return (1M):

Business Description

TNF Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms. Its MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. The MYMD-1 is being developed to treat diseases and disorders marked by acute or chronic inflammation. Show more

Price Returns Compared

Expand for Detailed View

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
TNFA Return	-38%	52%	-81%	-78%	-85%	-96%	-100%
Peers Return	75%	-16%	-34%	-21%	-51%	47%	-45%
S&P 500 Return	16%	27%	-19%	24%	23%	13%	106%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: VRTX, EDIT, INFIQ, SRNE, STA.
[3] 2025 data is for the year up to 9/29/2025 (YTD)

Better Bets than TNF Pharmaceuticals (TNFA)

	TNFA	Better Performance than TNFA
Metric	Value	Industry (Biotechnology)
Total Yield	-937.1%	ABBV (3.8%), AMGN (7.9%), GILD (7.3%), VRTX (3.6%), REGN (7.9%)

	TNFA	Better Performance than TNFA
Metric	Value	Sector (Health Care)
Total Yield	-937.1%	LLY (2.9%), JNJ (8.0%), ABBV (3.8%), UNH (9.3%), ABT (7.7%)

	TNFA	Better Performance than TNFA
Metric	Value	All Other Sectors
Total Yield	-937.1%	NVDA (2.0%), MSFT (3.3%), AAPL (3.0%), GOOGL (4.2%), AMZN (3.0%)

Trade Ideas

Select past trade ideas related to TNFA and Biotechnology.

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
LNTH_8312025_Dip_Buyer_High_CFO_Margins_ExInd_DE	08312025	LNTH	Lantheus	Dip Buy	DB \| CFO/Rev \| Low D/EDip Buy with High Cash Flow Margins Buying dips for companies with significant cash flows from operations and reasonable debt / market cap	-7.8%	-7.8%	-8.7%
COO_8312025_Monopoly_xInd_xCD_Getting_Cheaper	08312025	COO	Cooper Companies	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	0.2%	0.2%	-4.6%
WST_8312025_Monopoly_xInd_xCD_Getting_Cheaper	08312025	WST	West Pharmaceutical Services	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	5.9%	5.9%	-1.3%
BMY_7312025_Dip_Buyer_FCFYield	07312025	BMY	Bristol-Myers Squibb	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	1.9%	1.9%	0.0%
UTHR_7312025_Dip_Buyer_FCFYield	07312025	UTHR	United Therapeutics	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	57.5%	57.5%	0.0%

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
LNTH_8312025_Dip_Buyer_High_CFO_Margins_ExInd_DE	08312025	LNTH	Lantheus	Dip Buy	DB \| CFO/Rev \| Low D/EDip Buy with High Cash Flow Margins Buying dips for companies with significant cash flows from operations and reasonable debt / market cap	-7.8%	-7.8%	-8.7%
COO_8312025_Monopoly_xInd_xCD_Getting_Cheaper	08312025	COO	Cooper Companies	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	0.2%	0.2%	-4.6%
WST_8312025_Monopoly_xInd_xCD_Getting_Cheaper	08312025	WST	West Pharmaceutical Services	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	5.9%	5.9%	-1.3%
BMY_7312025_Dip_Buyer_FCFYield	07312025	BMY	Bristol-Myers Squibb	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	1.9%	1.9%	0.0%
UTHR_7312025_Dip_Buyer_FCFYield	07312025	UTHR	United Therapeutics	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	57.5%	57.5%	0.0%

See Trefis Trade Ideas for more.

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	WOLF	Wolfspeed	1726.4%	231.8%
2	BQ	Boqii	233.2%	153.9%
3	YCBD	cbdMD	121.2%	-54.0%
4	ENTA	Enanta Pharmaceuticals	91.9%	163.7%
5	JFB	JFB Construction	85.4%
6	TLRY	Tilray Brands	60.9%	39.1%
7	POAI	Predictive Oncology	54.8%	46.3%
8	SCOR	comScore	46.2%	53.3%
9	DWTX	Dogwood Therapeutics	43.3%	217.7%
10	BKKT	Bakkt	42.3%	3.1%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	MLTX	MoonLake Immunotherapeutics	-89.9%	-88.5%
2	KALA	Kala Bio	-89.3%	-70.5%
3	IOBT	IO Biotech	-76.9%	-60.3%
4	JZXN	Jiuzi	-60.3%	-69.5%
5	APLT	Applied Therapeutics	-50.7%	-28.5%
6	MTEK	Maris Tech	-50.6%	-58.9%
7	BIAF	bioAffinity Technologies	-38.6%	-88.1%
8	MTEN	Mingteng International	-38.0%	0.0%
9	BYND	Beyond Meat	-36.1%	-51.6%
10	LRMR	Larimar Therapeutics	-33.7%	-12.7%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	FTEL	Fitell	1068.4%	-96.0%
2	WOLF	Wolfspeed	886.6%	231.8%
3	WHLR	Wheeler Real Estate Investment Trust	404.4%	-99.7%
4	MNDR	Mobile-health Network Solutions	388.0%	-71.1%
5	QURE	uniQure	329.5%	236.4%
6	NUAI	New Era Energy & Digital	311.7%
7	BQ	Boqii	208.5%	153.9%
8	DVLT	Datavault AI	180.5%
9	DFLI	Dragonfly Energy	132.9%	-76.4%
10	SHFS	SHF	130.9%	-18.7%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	WOK	WORK Medical Technology	-91.5%	-98.5%
2	KALA	Kala Bio	-89.0%	-70.5%
3	MLTX	MoonLake Immunotherapeutics	-88.6%	-88.5%
4	SDM	Smart Digital	-87.5%	-83.8%
5	NRIM	Northrim BanCorp	-76.1%	14.0%
6	IOBT	IO Biotech	-75.5%	-60.3%
7	ZYBT	Zhengye Biotechnology	-74.9%
8	AMBI	Ambipar Emergency Response	-74.0%	-78.8%
9	FGL	Founder	-63.8%	-64.3%
10	BINI	Bollinger Innovations	-63.6%	-100.0%

1 Month Top Gainers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PMI	Picard Medical	13709.5%	13709.5%
2	TNFA	TNF Pharmaceuticals	7529.9%	-95.9%
3	QMMM	QMMM	2749.6%	9228.1%
4	WOLF	Wolfspeed	1757.1%	231.8%
5	EAF	GrafTech International	1199.0%	-24.2%
6	SEGG	Lottery.com	646.7%	-7.9%
7	SLNH	Soluna	435.8%	20.0%
8	PTNM	Pitanium	433.3%
9	NUAI	New Era Energy & Digital	395.6%
10	BREA	Brera	380.3%	3593.8%

1 Month Top Losers

#	Ticker	Company	1M Rtn	YTD Rtn
1	BINI	Bollinger Innovations	-96.1%	-100.0%
2	WOK	WORK Medical Technology	-90.8%	-98.5%
3	CJET	Chijet Motor	-90.3%	-92.7%
4	MLTX	MoonLake Immunotherapeutics	-88.6%	-88.5%
5	YAAS	Youxin Technology	-85.8%	-98.9%
6	ATYR	aTyr Pharma	-85.1%	-78.0%
7	CURX	Curanex Pharmaceuticals	-84.9%	28.8%
8	YYGH	YY	-84.6%	-80.3%
9	NEON	Neonode	-84.6%	-58.7%
10	SDM	Smart Digital	-82.5%	-83.8%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	WOLF	Wolfspeed	1726.4%	231.8%
2	BQ	Boqii	233.2%	153.9%
3	YCBD	cbdMD	121.2%	-54.0%
4	ENTA	Enanta Pharmaceuticals	91.9%	163.7%
5	JFB	JFB Construction	85.4%
6	TLRY	Tilray Brands	60.9%	39.1%
7	POAI	Predictive Oncology	54.8%	46.3%
8	SCOR	comScore	46.2%	53.3%
9	DWTX	Dogwood Therapeutics	43.3%	217.7%
10	BKKT	Bakkt	42.3%	3.1%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	MLTX	MoonLake Immunotherapeutics	-89.9%	-88.5%
2	KALA	Kala Bio	-89.3%	-70.5%
3	IOBT	IO Biotech	-76.9%	-60.3%
4	JZXN	Jiuzi	-60.3%	-69.5%
5	APLT	Applied Therapeutics	-50.7%	-28.5%
6	MTEK	Maris Tech	-50.6%	-58.9%
7	BIAF	bioAffinity Technologies	-38.6%	-88.1%
8	MTEN	Mingteng International	-38.0%	0.0%
9	BYND	Beyond Meat	-36.1%	-51.6%
10	LRMR	Larimar Therapeutics	-33.7%	-12.7%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	FTEL	Fitell	1068.4%	-96.0%
2	WOLF	Wolfspeed	886.6%	231.8%
3	WHLR	Wheeler Real Estate Investment Trust	404.4%	-99.7%
4	MNDR	Mobile-health Network Solutions	388.0%	-71.1%
5	QURE	uniQure	329.5%	236.4%
6	NUAI	New Era Energy & Digital	311.7%
7	BQ	Boqii	208.5%	153.9%
8	DVLT	Datavault AI	180.5%
9	DFLI	Dragonfly Energy	132.9%	-76.4%
10	SHFS	SHF	130.9%	-18.7%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	WOK	WORK Medical Technology	-91.5%	-98.5%
2	KALA	Kala Bio	-89.0%	-70.5%
3	MLTX	MoonLake Immunotherapeutics	-88.6%	-88.5%
4	SDM	Smart Digital	-87.5%	-83.8%
5	NRIM	Northrim BanCorp	-76.1%	14.0%
6	IOBT	IO Biotech	-75.5%	-60.3%
7	ZYBT	Zhengye Biotechnology	-74.9%
8	AMBI	Ambipar Emergency Response	-74.0%	-78.8%
9	FGL	Founder	-63.8%	-64.3%
10	BINI	Bollinger Innovations	-63.6%	-100.0%

Peer Comparisons for TNF Pharmaceuticals

Financials

	TNFA	VRTX	EDIT	INFIQ	SRNE	STA	Median
Name	TNF Phar.	Vertex P.	Editas M.	Infinity.	Sorrento.	Starton .
Mkt Price	4.70	395.31	3.52	-	-	-	4.70
Mkt Cap	0.0	101.5	0.3	-	-	-	0.3
Rev LTM	0	11,419	39	-	-	0	19
Op Inc LTM	-8	-199	-161	-	-	-11	-86
FCF LTM	-9	3,500	-205	-	-	-	-9
FCF 3Y Avg	-11	1,984	-182	-	-	-	-11
CFO LTM	-9	3,846	-201	-	-	-	-9
CFO 3Y Avg	-11	2,324	-177	-	-	-	-11

Growth & Margins

	TNFA	VRTX	EDIT	INFIQ	SRNE	STA	Median
Name	TNF Phar.	Vertex P.	Editas M.	Infinity.	Sorrento.	Starton .
Rev Chg LTM	-	10.5%	-42.0%	-	-	-	-15.8%
Rev Chg 3Y Avg	-	11.0%	55.3%	-	-	-	33.1%
Rev Chg Q	-	12.1%	597.5%	-	-	-	304.8%
QoQ Delta Rev Chg LTM	-	2.9%	8.6%	-	-	-	5.7%
Op Mgn LTM	-	-1.7%	-413.4%	-	-	-	-207.5%
Op Mgn 3Y Avg	-	26.5%	-616.5%	-	-	-	-295.0%
QoQ Delta Op Mgn LTM	-	2.0%	164.9%	-	-	-	83.5%
CFO/Rev LTM	-	33.7%	-517.6%	-	-	-	-242.0%
CFO/Rev 3Y Avg	-	22.5%	-538.7%	-	-	-	-258.1%
FCF/Rev LTM	-	30.6%	-526.8%	-	-	-	-248.1%
FCF/Rev 3Y Avg	-	19.2%	-552.8%	-	-	-	-266.8%

Valuation

	TNFA	VRTX	EDIT	INFIQ	SRNE	STA	Median
Name	TNF Phar.	Vertex P.	Editas M.	Infinity.	Sorrento.	Starton .
Mkt Cap	0.0	101.5	0.3	-	-	-	0.3
P/S	-	8.9	7.6	-	-	-	8.3
P/EBIT	-0.1	23.1	-1.3	-	-	-	-0.1
P/E	-0.1	27.9	-1.3	-	-	-	-0.1
P/CFO	-0.1	26.4	-1.5	-	-	-	-0.1
Total Yield	-937.1%	3.6%	-79.7%	-	-	-	-79.7%
Dividend Yield	0.0%	0.0%	0.0%	-	-	-	0.0%
FCF Yield 3Y Avg	-24,326.3%	2.1%	-61.3%	-	-	-	-61.3%
D/E	0.0	0.0	0.1	-	-	-	0.0
Net D/E	-5.2	-0.0	-0.5	-	-	-	-0.5

Returns

	TNFA	VRTX	EDIT	INFIQ	SRNE	STA	Median
Name	TNF Phar.	Vertex P.	Editas M.	Infinity.	Sorrento.	Starton .
1M Rtn	9,630.8%	1.1%	37.0%	-	-	-	37.0%
3M Rtn	-61.7%	-11.2%	60.0%	-	-	-	-11.2%
6M Rtn	-86.6%	-18.5%	203.4%	-	-	-	-18.5%
12M Rtn	-96.9%	-14.6%	1.1%	-	-	-	-14.6%
3Y Rtn	-99.9%	36.5%	-71.2%	-	-	-	-71.2%
1M Excs Rtn	7,527.4%	-1.6%	30.4%	-	-	-	30.4%
3M Excs Rtn	-69.1%	-18.6%	52.6%	-	-	-	-18.6%
6M Excs Rtn	-106.3%	-39.1%	162.2%	-	-	-	-39.1%
12M Excs Rtn	-113.5%	-30.8%	-12.6%	-	-	-	-30.8%
3Y Excs Rtn	-177.2%	-39.2%	-150.7%	-	-	-	-150.7%

Financials

Annual
Quarterly

$ Mil \| FY: 12/31	LTM	2024	2023	2022	2021	2020
Period End	6/30/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Filing Date	8/19/2025	4/11/2025	4/1/2024	3/31/2023	3/31/2022	3/31/2022
Key Financials
Total Revenue	0	0	0	0	0	0
EBITDA	-8	-9	-16	-15	-29	-8
Operating Income	-8	-9	-16	-15	-28	-8
Net Income	-7	-23	-4	-15	-30	-9
EPS	-231.00	-1115.00	-533.00	-1174.00	-2550.00	-766.51
Growth Rates
Total Revenue Growth	-	-	-	-	-	-
EBITDA Growth	37.6%	47.1%	-7.1%	47.8%	-253.7%	-
Operating Income Growth	37.6%	47.1%	-7.1%	45.8%	-239.9%	-
Net Income Growth	60.9%	-484.0%	73.7%	49.2%	-215.0%	-
Margins
EBITDA Margin	-	-	-	-	-	-
Operating Income Margin	-	-	-	-	-	-
Net Income Margin	-	-	-	-	-	-
Cash & Debt
Total Cash	4	9	5	5	12	0
Total Debt	0	0	0	0	0	4
Net Debt / (Cash)	-4	-9	-5	-5	-11	4
Cash Flows
Net Cash from Operations	-9	-9	-13	-12	-20	-5
Free Cash from Operations	-9	-9	-13	-12	-20	-5
Returns to Shareholders
Dividends	0	1	1	-0	-0	-0
Share Repurchases	-0	0	0	-0	-0	-0

$ Mil \| FY: 12/31	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3
Period End	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Filing Date	8/19/2025	5/15/2025	4/11/2025	11/14/2024	8/19/2024	5/15/2024	4/1/2024	11/14/2023	8/14/2023	5/15/2023	3/31/2023	11/10/2022
Key Financials Quarterly
Total Revenue	0	0	0	0	0	0	0	0	0	0	0	0
Ebitda	-2	-2	-2	-2	-2	-3	-5	-4	-6	-2	-4	-4
Operating Income	-2	-2	-2	-2	-2	-3	-5	-4	-6	-2	-4	-4
Net Income	-2	-1	-2	-2	-10	-10	-2	4	-4	-2	-4	-4
EPS	-18.00	-36.00	-66.00	-111.00	-454.00	-514.00	-305.00	184.00	-322.00	-120.00	-274.00	-270.00
Key Financials TTM
Total Revenue TTM	0	0	0	0	0	0	0	0	0	0	0	0
Ebitda TTM	-8	-8	-9	-11	-13	-17	-16	-15	-15	-13	-15	-15
Operating Income TTM	-8	-8	-9	-11	-13	-17	-16	-15	-15	-13	-15	-15
Net Income TTM	-7	-15	-23	-24	-18	-12	-4	-5	-13	-13	-15	-15
Growth Rates Quarterly
Total Revenue Growth	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth	-0.6%	11.2%	55.4%	52.5%	67.8%	-52.4%	-28.9%	-3.6%	-58.7%	55.7%	-14.3%	32.1%
Operating Income Growth	-0.6%	11.2%	55.4%	52.5%	67.8%	-52.4%	-28.9%	-3.6%	-58.7%	55.7%	-21.8%	15.8%
Net Income Growth	81.2%	88.5%	12.7%	-147.7%	-129.5%	-548.3%	36.9%	209.5%	-14.6%	63.3%	-15.6%	32.4%
Margins Quarterly
EBITDA Margin	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Margin	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Margin	-	-	-	-	-	-	-	-	-	-	-	-
Cash & Debt
Total Cash	4	6	9	11	13	2	5	8	12	16	5	7
Total Debt	0	0	0	0	0	0	0	0	0	0	0	0
Net Debt / (Cash)	-4	-6	-9	-11	-13	-2	-5	-8	-12	-15	-5	-7
Cash Flows Quarterly
FCF from Operations	-2	-3	-1	-4	-3	-2	-2	-3	-4	-4	-2	-4
Cash Flows TTM
FCF from Operations TTM	-9	-10	-9	-10	-10	-11	-13	-13	-14	-14	-12	-15
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-0	-0	-0	-0	-0	0	0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	-5.3%	-7.1%	-6.5%	-5.5%	-6.7%	-9.2%	-17.9%	-14.7%	-23.3%	-7.8%	-14.7%	-14.6%
Return on Invested Capital (ROIC) TTM
ROIC TTM	-5.9%	-6.0%	-6.4%	-8.6%	-12.1%	-14.3%	-14.9%	-14.6%	-15.2%	-13.8%	-14.7%	-14.4%

Price Behavior

Behavior Stats
Betas Matrix

Price Behavior

Market Price	$4.70
Market Cap ($ Bil)	0.1
First Trading Date	07/24/2008
Distance from 52W High	-97.4%
	50 Days	200 Days
DMA Price	$7.26	$40.27
DMA Trend	down	down
Distance from DMA	-35.3%	-88.3%
	3M	1YR
Volatility	15,794.8%	7,849.1%
Downside Capture	-4029.93	-216.62
Upside Capture	-2690.70	-521.42
Correlation (SPY)	-18.9%	-4.0%

TNFA Betas & Captures as of 8/31/2025

	1M	2M	3M	6M	1Y	3Y
Beta	-1.74	-1.43	0.46	0.47	0.24	0.91
Up Beta	10.07	-2.28	0.27	0.11	-0.29	0.64
Down Beta	6.94	7.29	5.52	0.65	0.35	0.85
Up Capture	-1373%	-855%	-474%	-120%	-58%	-5%
Bmk +ve Days	10	22	35	71	142	415
Stock +ve Days	7	17	26	54	106	307
Down Capture	800%	708%	614%	207%	161%	109%
Bmk -ve Days	11	19	27	54	106	334
Stock -ve Days	14	25	37	71	140	420

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date	9152025
Short Interest: Shares Quantity	311,340
Short Interest: % Change Since 8312025	-94.6%
Average Daily Volume	626,202
Days-to-Cover Short Interest	1
Basic Shares Quantity	156,988
Short % of Basic Shares	198.3%

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
11/15/2018	-29.5%	-25.6%	-55.9%
SUMMARY STATS
# Positive	0	0	0
# Negative	1	1	1
Median Positive
Median Negative	-29.5%	-25.6%	-55.9%
Max Positive
Max Negative	-29.5%	-25.6%	-55.9%

	Forward Returns
11/15/2018	-29.5%	-25.6%	-55.9%
SUMMARY STATS
# Positive	0	0	0
# Negative	1	1	1
Median Positive
Median Negative	-29.5%	-25.6%	-55.9%
Max Positive
Max Negative	-29.5%	-25.6%	-55.9%

SEC Filings

Expand for More

Report Date	Filing Date	Filing
6302025	8192025	10-Q 6/30/2025
3312025	5152025	10-Q 3/31/2025
12312024	4112025	10-K 12/31/2024
9302024	11142024	10-Q 9/30/2024
6302024	8192024	10-Q 6/30/2024
3312024	5152024	10-Q 3/31/2024
12312023	4012024	10-K 12/31/2023
9302023	11142023	10-Q 9/30/2023
6302023	8142023	10-Q 6/30/2023
3312023	5152023	10-Q 3/31/2023
12312022	3312023	10-K 12/31/2022
9302022	11102022	10-Q 9/30/2022
6302022	8152022	10-Q 6/30/2022
3312022	5162022	10-Q 3/31/2022
12312021	3312022	10-K 12/31/2021
9302021	11122021	10-Q 9/30/2021

Insider Activity

Expand for More

Industry Resources

Health Care Resources

U.S. National Library of Medicine

Health Data Management

FDA Tracker

Biotechnology Resources

Fierce Biotech

Nature Biotechnology

Genetic Engineering & Biotechnology News

Biotechnology Innovation Organization

BioWorld

BioTechniques

HBS Biotechnology Publications

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

TNF Pharmaceuticals (TNFA)

Market Price (9/30/2025): $4.04 | Market Cap: $0.6 MilSector: Health Care | Industry: Biotechnology

TNF Pharmaceuticals (TNFA)

Market Price (9/30/2025): $4.04Market Cap: $0.6 MilSector: Health CareIndustry: Biotechnology

Investment Highlights

Market Valuation

Business Description

Price Returns Compared

Interactive Breakdown

Better Bets than TNF Pharmaceuticals (TNFA)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for TNF Pharmaceuticals

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (9/30/2025): $4.04 | Market Cap: $0.6 Mil
Sector: Health Care | Industry: Biotechnology

Market Price (9/30/2025): $4.04
Market Cap: $0.6 Mil
Sector: Health Care
Industry: Biotechnology